Concepedia

J. A. Bijl

JA

Statistics

Publications

4

Citations

2.4K

H-Index

4

Active since

1994

Affiliations

Leiden University(Current)

J. A. Bijl is an author at Leiden University specializing in rheumatoid arthritis, rheumatology, and monoclonal antibodies.

Publications per year

1994–1996

4

Publications

4

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann et al. · The Lancet · 1994 · 1.7K citations

Medicine, Clinical Sciences, Immunology +15

Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

Michael J. Elliott, Ravinder N. Maini, Marc Feldmann et al. · The Lancet · 1994 · 643 citations

Life Sciences, Clinical Sciences, Immunology +13

Percentage of anti‐CD4 monoclonal antibody‐coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens

Ernest Choy, Costantino Pitzalis, Alberto Cauli et al. · Arthritis & Rheumatism · 1996 · 68 citations

Medicine, Immunology, Pharmacotherapy +17

Treatment of Rheumatoid Arthritis with a Chimeric CD4 Monoclonal Antibody (cM‐T412): Immunopharmacological Aspects and Mechanisms of Action

Peter A. Van Der Lubbe, Christian Reiter, A. M. M. Miltenburg et al. · Scandinavian Journal of Immunology · 1994 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–4 of 4